ID: ALA4750764

Max Phase: Preclinical

Molecular Formula: C40H63N11O6

Molecular Weight: 794.01

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@@H]1NC(=O)[C@H](C(C)(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC1=O

Standard InChI:  InChI=1S/C40H63N11O6/c1-23(2)20-29-34(53)46-27(15-10-18-44-39(42)43)33(52)47-28(14-8-9-17-41)38(57)51-19-11-16-31(51)36(55)48-30(21-24-22-45-26-13-7-6-12-25(24)26)35(54)50-32(37(56)49-29)40(3,4)5/h6-7,12-13,22-23,27-32,45H,8-11,14-21,41H2,1-5H3,(H,46,53)(H,47,52)(H,48,55)(H,49,56)(H,50,54)(H4,42,43,44)/t27-,28-,29-,30-,31-,32+/m0/s1

Standard InChI Key:  NLOPJQKBRDOXGW-VRBLGLBQSA-N

Associated Targets(non-human)

Ntsr1 Neurotensin receptor 1 (48 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 794.01Molecular Weight (Monoisotopic): 793.4963AlogP: 0.62#Rotatable Bonds: 12
Polar Surface Area: 269.52Molecular Species: BASEHBA: 8HBD: 10
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.54CX Basic pKa: 12.03CX LogP: -0.47CX LogD: -4.69
Aromatic Rings: 2Heavy Atoms: 57QED Weighted: 0.08Np Likeness Score: 0.72

References

1. Chartier M,Desgagné M,Sousbie M,Côté J,Longpré JM,Marsault E,Sarret P.  (2021)  Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.,  64  (4.0): [PMID:33538583] [10.1021/acs.jmedchem.0c01726]

Source